A pharmaceutical giant approached Freyr for assistance in drafting and finalizing multiple ICFs for clinical phases 1-3 for multiple molecules in the USA and EU Region. Freyr supported the client to overcome ambiguity and inconsistency of source documents, and to author ICFs within stringent timelines.
Download the case study to decode how Freyr managed to support 60+ various types of ICFs and delivered the first drafts in under 3 days.
Fill the form below to download the Case Study
